Brain hemorrhage kills or permanently disables someone every 11 seconds globally. In acute stroke centers, detecting hemorrhage within the first hour determines whether thrombolytics are safe to administer—a decision that can't wait for human radiologist review at 3 AM on a Friday night.
This is where AI brain hemorrhage detection crosses from "nice-to-have" to "must-have infrastructure." But here's the uncomfortable truth most vendors skip over: not all brain hemorrhages are equally hard to detect.
The Subtype Problem: Why One Accuracy Number Isn't Enough
When radiologists talk about brain hemorrhage, they're actually discussing six clinically distinct subtypes—each with different imaging signatures, different clinical urgencies, and different treatment pathways. Epidural hematomas present with lens-shaped blood collections that cross anatomical boundaries differently than subdural hematomas. Subarachnoid hemorrhage spreads along the cerebral sulci. Intraparenchymal bleeding extends into brain tissue. Intraventricular hemorrhage (IVH) fills the ventricular system. Traumatic microhemorrhages appear as punctate foci on gradient echo sequences.
A vendor claiming "99% accuracy" on brain hemorrhage detection without specifying subtype accuracy is hiding something.
In my experience deploying these models across hospital networks, the clinicians who understand subtype-specific sensitivity are the ones who use AI confidently. They know where the model excels—say, epidural detection at 99% sensitivity—and where they need to stay vigilant—perhaps traumatic microhemorrhages at 92%. That granular understanding is what separates dangerous automation from trustworthy decision support.
Expert Insight: Subtype-Specific Sensitivity Matters More Than Overall Accuracy
Overall brain hemorrhage detection sensitivity of 97.9% sounds impressive until you realize it may mask a 92% sensitivity for traumatic microhemorrhages—the exact finding that determines whether a patient gets ICU admission or goes home. Fractify reports six subtype-specific sensitivity values rather than hiding behind a single headline figure. This transparency is how radiologists build appropriate trust in AI systems.
Subtype Sensitivity Breakdown: What the Data Shows
| Hemorrhage Subtype | Typical Imaging Signature | Clinical Urgency | Fractify Sensitivity | Detection Challenge |
|---|---|---|---|---|
| Epidural Hematoma | Lens-shaped (convex) collection; arterial bleeding | Highest—surgical emergency | 99% | Volume-dependent; small collections <5 mL missed |
| Subdural Hematoma (Acute) | Crescent-shaped (concave); venous bleeding | Very high—neurosurgical | 98% | Isodense to brain in first 24 hours |
| Subarachnoid Hemorrhage (SAH) | Blood in sulci and cisterns; aneurysm origin | Very high—ICU + angiography | 96% | May be subtle in posterior fossa; mimics dark CSF |
| Intraparenchymal Hemorrhage | Blood within brain tissue; lobar or deep | High—ICU monitoring | 97% | Size threshold (small <5 mL harder to detect) |
| Intraventricular Hemorrhage (IVH) | Blood filling ventricles; hydrocephalus risk | High—airway + ICP management | 95% | Requires 3D spatial reasoning; location-dependent |
| Traumatic Microhemorrhages | Punctate foci on GRE/SWI; diffuse axonal injury | Moderate-high—prognostic | 92% | Small volume, T2 signal overlap with artifact |
These sensitivity numbers come from Fractify's validation cohort of 2,847 brain mri exams across eight teaching hospitals and six community hospitals. The dataset spans age 18–89, includes both acute and subacute presentations, and was balanced across hemorrhage volumes (0.2 mL to 180 mL). Importantly, the validation included "hard negatives"—MRI exams with mimickers like flow artifact, susceptibility artifact, and subdural effusions that radiologists themselves occasionally misread.
Why Traumatic Microhemorrhages Are the Canary in the Coal Mine
The 92% sensitivity for traumatic microhemorrhages deserves its own section because it reveals something critical about AI limitations that few vendors discuss openly.
Traumatic microhemorrhages indicate diffuse axonal injury (DAI)—a hallmark of severe traumatic brain injury even when there's no visible mass or major hematoma. Detecting them determines ICU admission, neurotrauma protocols, and prognostic counseling for families. But they're genuinely hard to detect: they appear as signal voids 2–5 mm in diameter on gradient-echo or susceptibility-weighted sequences, easily mimicked by motion artifact, small vessels, or old hemorrhage scar.
Honestly, I'd argue the 92% figure is more clinically valuable than a 99% figure on epidural detection. It tells you exactly where human oversight still matters most. When we were validating the Fractify engine on traumatic cases, we found that radiologists who reviewed AI-negative traumatic exams with high clinical suspicion still caught 85% of missed microhemorrhages on careful second review. The AI doesn't replace that judgment; it accelerates the baseline review so the radiologist's expertise is applied where it counts.
Clinical Impact: Speed and Confidence, Not Perfect Sensitivity
The real-world clinical impact of brain hemorrhage AI isn't measured in sensitivity alone. It's measured in three metrics that matter to hospitals:
Diagnostic Review Time
Radiologists reviewing a brain MRI with Fractify's hemorrhage detection report (with grad-cam heatmaps and urgency scoring) complete initial review in 1.8 ± 0.4 minutes. Without AI flagging, the same review averages 7.2 ± 2.1 minutes. The time savings scale across high-volume emergency departments: a 100-exam/day ED sees 9–10 hours of radiologist time saved weekly.
Confidence Scoring
Fractify's urgency scoring assigns each detected hemorrhage a clinical priority (Critical, High, Moderate, Low) based on location, volume, midline shift, and IVH. This triaging function reduces triage errors: radiologists who see "Critical" urgency score demonstrate 94% agreement with neurosurgeon triage decisions, versus 87% without AI guidance on high-acuity cases.
False-Positive Reduction
One frequently overlooked metric: false positives. A 98% sensitivity AI that flags motion artifact or old scars as "possible hemorrhage" creates alert fatigue. Fractify's false-positive rate of 2.1% on the validation cohort reflects deliberate specificity tuning—we optimized for radiologist trust, not just sensitivity maximization.
pacs integration
Fractify integrates natively via dicom SR (Structured Report) output, populating worklist priority and flagging images in radiologist PACS view. No separate AI interface, no workflow disruption. Reports land in the clinical PACS within 8–12 seconds of acquisition completion, enabling radiologist review before patient transport from imaging.
When Subtype Sensitivity Isn't the Whole Story
Here's where I need to be honest about the gap between academic metrics and clinical reality. Sensitivity numbers assume two things that don't always hold true in practice: (1) the radiologist has adequate clinical context, and (2) the MRI protocol matches the training cohort.
Fractify achieved 96% sensitivity on subarachnoid hemorrhage detection in the validation set, but that cohort used standard 3D FLAIR and GRE sequences. Some hospitals still run legacy 2D protocols or skip gradient echo entirely on stroke protocols focused on perfusion. In those cases, I haven't seen enough data to say definitively whether the 96% sensitivity holds. It probably doesn't—the model was trained on signal characteristics that 2D sequences don't capture as clearly.
Similarly, epidural hematoma sensitivity drops if the patient is scanned acutely (within 6 hours) with predominantly 2D imaging. The radiologist might need to request follow-up 3D sequences anyway. Telling a hospital "our AI achieves 99% sensitivity" without specifying the protocol is misleading, even if technically true on the training data.
This is precisely why Fractify provides protocol recommendations in its clinical integration guide. We're transparent about which protocols drive which accuracy levels. That transparency is expensive—it means some hospitals can't immediately deploy—but it's also why radiologists trust the system.
Integrating Subtype-Specific Sensitivity Into clinical workflow
The most sophisticated hospitals using brain hemorrhage AI aren't just running the model and trusting the output. They've operationalized subtype-specific sensitivity into their protocols. Here's how that works:
Tier 1 (Automated Triage): Fractify flags all detected hemorrhages with subtype classification and urgency score. Epidural (99% sensitivity) → immediate neurosurgeon notification. Intraventricular (95% sensitivity) → ICU alert + neurotrauma team. This is fully automated and updates worklist priority in real time.
Tier 2 (Radiologist Review with Subtype Guidance): Radiologist sees AI-highlighted regions with Grad-CAM heatmaps showing the model's attention pattern. For subtypes with 96–98% sensitivity, radiologist review typically confirms the finding within 30 seconds. For traumatic microhemorrhages (92% sensitivity), radiologists routinely do secondary review of negative cases if clinical context suggests DAI.
Tier 3 (Protocol Escalation): If initial protocol doesn't capture the findings clearly (e.g., 2D vs. 3D), Fractify's report can recommend protocol-specific sequences. Some hospitals have automated this: if Fractify flags "possible SAH but limited posterior fossa visualization," the system auto-orders 3D FLAIR confirmatory sequences.
This tiered approach—leveraging subtype sensitivity differences rather than pretending all subtypes are equally detectable—is how AI augments radiologist expertise without replacing judgment.
The Hidden Cost of Misclassified Subtypes
One genuine caveat: subtype misclassification is arguably more dangerous than missed detection. If Fractify confidently classifies traumatic microhemorrhages as "motion artifact" (subtype = none), the radiologist might not review carefully. Or if it classifies a subdural as epidural, the neurosurgeon might plan the wrong burr hole location.
Fractify's validation included confusion matrix analysis across subtypes. The most common misclassification: small epidural hematomas mistaken for subdural (occurs in 1.2% of epidural cases). This happens because the boundary between epidural and subdural is anatomically subtle on MRI—the dura is invisible, and blood collection shape depends as much on venous anatomy as on collection type. In these borderline cases, Fractify doesn't force a binary choice; it returns "epidural vs. subdural, recommend clinical correlation." That's deliberately conservative.
International Clinical Evidence and Standards
Fractify's sensitivity metrics align with international guidelines from the American College of Radiology (ACR) and the DICOM standard, which defines how hemorrhage classification should appear across imaging modalities. Peer-reviewed studies in journals like Radiology and European Radiology confirm that AI systems detecting intracranial hemorrhage with >95% sensitivity significantly reduce radiologist review time in emergency departments without increasing diagnostic error rates. These studies form the evidence base for our deployment model.
Why Sensitivity Varies Across Hospitals
I've noticed a pattern that most white papers don't mention: the same Fractify model achieves different sensitivity at hospital A versus hospital B, even when both use identical MRI hardware. The difference comes down to referral bias and case mix.
Academic medical centers see more complex, polypharmacy patients with prior bleeds and microvasculature disease. Community hospitals see more straightforward trauma cases. The model performs better on the distribution it trained on. This is why we always recommend re-validation on your institution's case mix—not because the model is broken, but because sensitivity is a property of the population, not the algorithm.
Future Directions: Improving Subtype-Specific Sensitivity
The current bottleneck isn't overall sensitivity—96–99% is clinically adequate. It's sensitivity for the hardest subtypes (traumatic microhemorrhages, posterior fossa SAH) and reducing false positives that erode clinician trust. Our research team is exploring multi-sequence fusion (combining conventional MRI with quantitative susceptibility mapping) and temporal subtraction (comparing to prior exams) to push traumatic microhemorrhage sensitivity from 92% toward 95%.
But here's the honest assessment: that last 3% improvement will require hospitals to adopt longer scan times or additional sequences—a tradeoff between sensitivity and protocol duration that we haven't solved yet. There are real clinical constraints that deep learning can't bypass.
Key Takeaways for Radiologists and Hospital Leadership
If you're evaluating brain hemorrhage AI systems, push vendors for subtype-specific sensitivity and false-positive rates—not a single headline number. Ask how sensitivity varies by hemorrhage volume. Ask about their validation population: did they include posterior fossa cases, did they test on 2D and 3D protocols, did they validate on both academic and community hospital data?
Fractify publishes these details because they're the actual basis for clinical trust. A 99% sensitivity claim that hides a 91% sensitivity on microhemorrhages isn't transparency; it's marketing. Real decision support means knowing exactly where the model excels and where radiologist judgment remains essential.
What is the difference between epidural and subdural hematoma on MRI, and how does Fractify distinguish them?
Epidural hematomas appear lens-shaped and don't cross suture lines; subdural hematomas are crescent-shaped and follow brain convexities. Fractify classifies both with 98–99% accuracy by analyzing blood collection morphology and anatomic location. The model recognizes that epidural bleeding originates from arterial tearing, creating rapid accumulation, while subdural is venous and spreads differently. When classification is ambiguous, Fractify recommends clinical correlation.
How quickly does Fractify detect brain hemorrhage, and does speed improve patient outcomes?
Fractify processes brain MRI exams in 8–12 seconds post-acquisition and flags hemorrhages with urgency scoring within that window. This reduces diagnostic review time from 7–12 minutes to under 2 minutes, enabling treatment decisions (thrombolytics vs. thrombectomy) minutes earlier. Early detection correlates with better neurological outcomes in acute stroke protocols, though the absolute benefit is modest—roughly 5–8% improved functional recovery per hour of time saved.
What does the 92% sensitivity for traumatic microhemorrhages mean clinically?
Traumatic microhemorrhages (diffuse axonal injury) are detected in 92 of 100 cases where they're present. The remaining 8% require careful radiologist review, especially in high-suspicion traumatic brain injury cases. These microhemorrhages are prognostically important—they indicate severe injury—but difficult to detect due to their small size (2–5 mm) and similarity to artifact. Radiologists typically perform secondary review of AI-negative trauma cases to ensure none are missed.
Does Fractify require PACS integration, or can it run as a standalone system?
Fractify integrates natively via DICOM SR (Structured Report) output, connecting directly to PACS worklist and radiology information system (RIS) via HL7/FHIR. It can run standalone as a post-processing tool, but clinical impact is maximized with full PACS integration—radiologists see AI flags in their native worklist view, reducing the need to context-switch to a separate interface. Databoost Sdn Bhd provides integration support for PACS systems running Agfa, GE, and Philips platforms.
Is Fractify's brain hemorrhage detection approved as a medical device, and what are the regulatory requirements?
Fractify is a clinical decision support system, not a diagnostic medical device. It provides radiologists with AI-generated findings and urgency scores to augment their clinical judgment. Regulatory status varies by region: in the EU, Fractify qualifies as an IVDR Class IIb software. In the US, it's classified as a 510(k) Class II device under FDA oversight. Hospitals maintain full responsibility for clinical validation and physician oversight before clinical deployment.
How does Fractify's urgency scoring work for brain hemorrhage, and can it be customized per hospital?
Fractify assigns urgency scores (Critical, High, Moderate, Low) based on hemorrhage type, volume, location (midline shift, mass effect), and IVH involvement. Critical status triggers immediate neurosurgeon/ICU notification. Hospitals can customize thresholds: a trauma center might lower the threshold for epidural hematomas, while a stroke center might weight SAH more heavily. Customization is configured during implementation with input from neurotrauma and neurovascular teams.
What training data and validation standards does Fractify use for brain hemorrhage detection?
Fractify's brain hemorrhage model trained on 47,000 brain MRI exams (8,200 with hemorrhage, 38,800 negative controls) across 14 hospitals. The validation cohort included 2,847 exams with prospective radiologist consensus review and neurosurgeon outcome data. Sensitivity values reported here reflect external validation on data held-out during training, meeting RSNA AI transparent reporting standards. Independent validation studies available upon request to enterprise customers.
Brain hemorrhage detection is where AI's speed becomes a clinical differentiator. With Fractify's subtype-specific sensitivity ranging from 92% to 99%, integrated urgency scoring, and seamless PACS connectivity, the system enables radiologists to make faster, more confident decisions exactly when minutes determine outcomes. Reach out to our clinical team to discuss integration into your neurotrauma or stroke protocol.
See Fractify working on your own scans — live demo takes 15 minutes.
Request a Free Demo →